GoodRx Disrupts Pharmacy Economics with Cost-Plus Pricing
GoodRx reshapes independent pharmacy economics through transparent cost-plus pricing model launch.
GoodRx reshapes independent pharmacy economics through transparent cost-plus pricing model launch.
Medacta highlights cutting-edge orthopedic innovations at ISAKOS 2024.
Two-fold increased risk prompts label updates for blockbuster GLP-1 drugs.
Medical distributor abandons home healthcare consolidation play.
Dupixent shows 76% efficacy in patients with darker skin tones.
Medtronic recalls Shiley trach tubes over flange detachment causing airway complications.
J&J’s $147M antitrust penalty tripled to $442M for monopolizing cardiac catheter market.
Major insurers endorse billing limits on controversial home-based risk assessments.
Regional HTA network addresses equity, economic evaluation, and adaptation frameworks.
Platform achieves 30% market dominance in Medicare Advantage bid submissions.